Amrize (NYSE:AMRZ) Stock Price Expected to Rise, Truist Financial Analyst Says

Amrize (NYSE:AMRZ) had its price objective increased by stock analysts at Truist Financial from $60.00 to $75.00 in a research report issued on Friday, MarketBeat reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s target price would suggest a potential upside of 15.29% from the stock’s current price.

Other equities research analysts have also issued research reports about the company. Vertical Research assumed coverage on Amrize in a research note on Tuesday, November 25th. They issued a “hold” rating and a $54.00 target price for the company. Oppenheimer reaffirmed an “outperform” rating and issued a $70.00 price target (up from $64.00) on shares of Amrize in a research note on Thursday. UBS Group increased their price objective on Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, January 8th. Oddo Bhf assumed coverage on shares of Amrize in a report on Monday, November 3rd. They issued a “neutral” rating on the stock. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $70.00 price target on shares of Amrize in a report on Thursday, December 18th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $63.43.

Amrize Price Performance

Shares of Amrize stock opened at $65.06 on Friday. Amrize has a 52-week low of $44.12 and a 52-week high of $65.26. The stock has a market capitalization of $35.98 billion and a price-to-earnings ratio of 35.36. The company has a fifty day moving average of $56.08 and a 200-day moving average of $52.50. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.97 and a current ratio of 1.64.

Amrize (NYSE:AMRZ) last issued its earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The business had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. The company’s revenue was down .4% on a year-over-year basis.

Institutional Trading of Amrize

Large investors have recently added to or reduced their stakes in the stock. MCF Advisors LLC bought a new position in Amrize in the 4th quarter worth $27,000. State of Wyoming purchased a new position in shares of Amrize during the third quarter valued at about $32,000. Basepoint Wealth LLC bought a new position in Amrize in the fourth quarter worth about $33,000. Laurel Wealth Advisors LLC bought a new stake in Amrize during the 4th quarter valued at approximately $34,000. Finally, US Bancorp DE bought a new stake in Amrize during the 3rd quarter valued at approximately $38,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.